[go: up one dir, main page]

DK1237571T3 - Toscana-virus-nukleinprotein - Google Patents

Toscana-virus-nukleinprotein

Info

Publication number
DK1237571T3
DK1237571T3 DK00987600T DK00987600T DK1237571T3 DK 1237571 T3 DK1237571 T3 DK 1237571T3 DK 00987600 T DK00987600 T DK 00987600T DK 00987600 T DK00987600 T DK 00987600T DK 1237571 T3 DK1237571 T3 DK 1237571T3
Authority
DK
Denmark
Prior art keywords
toscana virus
virus
nukleinprotein
toscana
antigen
Prior art date
Application number
DK00987600T
Other languages
English (en)
Inventor
Maria Grazia Cusi
Marcello Valassina
Pier Egisto Valensin
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Application granted granted Critical
Publication of DK1237571T3 publication Critical patent/DK1237571T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/12011Bunyaviridae
    • C12N2760/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/12011Bunyaviridae
    • C12N2760/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DK00987600T 1999-12-16 2000-12-18 Toscana-virus-nukleinprotein DK1237571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein
PCT/IB2000/002031 WO2001044288A2 (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein

Publications (1)

Publication Number Publication Date
DK1237571T3 true DK1237571T3 (da) 2008-01-02

Family

ID=10866464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987600T DK1237571T3 (da) 1999-12-16 2000-12-18 Toscana-virus-nukleinprotein

Country Status (10)

Country Link
EP (1) EP1237571B1 (da)
AT (1) ATE374040T1 (da)
AU (1) AU2390101A (da)
CY (1) CY1107607T1 (da)
DE (1) DE60036563T2 (da)
DK (1) DK1237571T3 (da)
ES (1) ES2293934T3 (da)
GB (1) GB9929783D0 (da)
PT (1) PT1237571E (da)
WO (1) WO2001044288A2 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
ITMI980889A1 (it) * 1998-04-24 1999-10-24 Diesse Diagnostica Nucleoproteina ricombinante del virus toscana

Also Published As

Publication number Publication date
WO2001044288A2 (en) 2001-06-21
EP1237571B1 (en) 2007-09-26
DE60036563D1 (de) 2007-11-08
AU2390101A (en) 2001-06-25
EP1237571A2 (en) 2002-09-11
ES2293934T3 (es) 2008-04-01
DE60036563T2 (de) 2008-07-17
PT1237571E (pt) 2007-12-31
CY1107607T1 (el) 2013-03-13
WO2001044288A3 (en) 2002-01-24
GB9929783D0 (en) 2000-02-09
ATE374040T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
WO2007130493A3 (en) Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
CY1118521T1 (el) Συνθεση εμβολιου και μεθοδος χρησης αυτου
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
NO20015073L (no) Vaksiner
DE60121136D1 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
FR2814958B1 (fr) Composition vaccinale
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE60039715D1 (de) Hcv-impfstoff zusammensetzungen
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
MX2023009447A (es) Anticuerpos que se unen a metapneumovirus, proteínas antigénicas de metapneumovirus, y usos de los mismos.
PL1949913T3 (pl) Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
DK1237571T3 (da) Toscana-virus-nukleinprotein
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
ATE401392T1 (de) Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis